BJDX · Bluejay Diagnostics Inc
United States · RS rating 7 · As of 2026-10-14
| Price | 0.79 USD |
|---|---|
| 1-day change | -5.4% |
| RS rating (overall / 1M / 3M / 12M) | 7 / 30 / 8 / 3 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 27 / 4 / 51 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +42.6% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +94.4% |
| Market cap (USD) | $2.0M |